BioSpace News Archive

Deals

Owens & Minor Declares 1st Quarter 2019 Dividend payable on March 29, 2019

Owens & Minor, Inc. announced that its Board of Directors has approved a first quarter dividend payment of $0.0025 per share.

February 19, 2019

·

1 min read

BioMidwest

NextLevel Health Partners, Inc., Morehouse School of Medicine And The Illinois Legislative Black Caucus Foundation Launch The Advancing Men’s Health Through Primary Care Conference

Dr. Ian Smith Will Keynote The Conference To Address The Social Determinants For Men’s Primary Healthcare

February 19, 2019

·

4 min read

BioMidwest

Illinois Medical District And IGNITE CITIES Announce The Launch Of Country’s First Smart Medical District

Innovative Partnership Will Transform Transportation, Connectivity and Safety Throughout The Nation’s Second Largest Urban Medical District

February 19, 2019

·

3 min read

Policy

Teva Finalizes Settlement with Federal Trade Commission to Resolve All Outstanding Litigation between the Parties

Teva Pharmaceutical Industries Ltd. announced a settlement with the Federal Trade Commission that will resolve all outstanding litigation between the parties.

February 19, 2019

·

6 min read

Deals

/C O R R E C T I O N -- Theravance Biopharma, Inc./

In the news release, Theravance Biopharma to Report Fourth Quarter and Full Year 2018 Financial Results on February 26, issued 19-Feb-2019 by Theravance Biopharma, Inc.

February 19, 2019

·

3 min read

Business

Cellular Biomedicine Group Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Operational Progress

Obtained NCI Patent License for Next Generation Neoantigen-Reactive Tumor Infiltrating Lymphocyte (TIL) Technology to Treat Solid Tumors

February 19, 2019

·

14 min read

Job Trends

AveXis to Expand Its NC Manufacturing Facility, Plans to Hire 200

On Monday, N.C. Gov. Roy Cooper announced the expansion to the company’s Durham facility that was first announced in May 2018. It’s expected to provide up to 200 additional jobs.

February 19, 2019

·

2 min read

·

Alex Keown

Drug Development

Intercept Pharma Is One Step Closer to Filing for Approval of First NASH Treatment

Intercept Pharma plans to seek regulatory approval in the U.S. and Europe in the second half of this year.

February 19, 2019

·

2 min read

·

Alex Keown

Drug Development

Inventiva Discontinues Systemic Sclerosis Drug After Mid-Stage Flop

Shares of France-based Inventiva have plunged more than 45 percent after the company reported that its experimental treatment for a rare autoimmune disease failed to hit primary and secondary endpoints in a mid-stage trial.

February 19, 2019

·

2 min read

·

Alex Keown

Business

Teva Eyes 25 Percent of the $750 Million EpiPen Market by Year’s End

Teva Pharmaceuticals is expecting big things from its generic EpiPen. The company snagged approval for its generic version of Mylan’s EpiPen Auto-Injector in August 2018.

February 19, 2019

·

2 min read

·

Alex Keown